Newdrugapprovalprocess: accelerating global registrations
Author: Guarino, Richard A. ISBN: 0-8247-5041-1
Pharmaceuticalindustryprofessionals unturn intheclinical, regulatory, statistical, and legal developmentofnewdrugs, ace well expert pharmacists, pharmacologists, clinicalinvestigators, and graduate andupper-levelundergraduatestudentswhointendtopursuecareersinthepharmaceuticalindustry. PARTIALCONTENTS RegulatoryPracticesandProceduresof New Drug, Biologicsand Device Development New Product Development Teams Duane B. Lakings Nonclinical Drug Development: Pharmacology, Drug Metabolism, andToxicology Duane B. Lakings The Investigational New Drug Application (IND)andthe Investigatorfs Brochure (IB) @William M. Troetel Clinical Research Development Clinical Research Protocols Richard A. Guarino AdverseExperiences, Adverse Reactions and InteractionsofDrugs Richard A. Guarino Statisticaland Data Management Collaborationin Clinical Research
Mark Bradshaw and Lawrence A. Meinert SpecificAspectsintheProcessof New Product Submissions Chemistry, Manufacturingand Control (CMC)RequirementsoftheNDAand ANDA Evan Siegel
Byline PresentationforFDASubmissions: Textand Tabular Exposition Patricia Blaine PreparingforFDAInspections: Manufacturing Site Timothy Urschel
Global Applicationsof Good Clinical Practices(GCPs) ObligationsoftheInvestigator, Sponsorand Monitor Richard A. Guarino Institutional Review Board (IRB) /Independent Ethics Committee (IEC)and Informed Consent (IC): ProtectingSubjectsthroughoutthe Clinical Research Process Rochelle L. Goodson QualityAssuranceEarl W. Hulihan
If you believe that some link is missing that it could be interesting send it to us